Allopurinol / m04a a01

Product description

Borshchahivskiy cpp (bcpp) offers a wide range of medicinal products which includes allopurinol / m04a a01. Active ingredients: it is a xanthine-oxidase inhibitor and is used for the treatment of gout. Allopurinol and its main metabolite oxipurinol lower the level of uric acid in plasma and urine by inhibition of xanthine oxidase, the enzyme catalyzing the oxidation of hypoxanthine to xanthine and xanthine to uric acid. This reduces serum urates and prevents their accumulation in the tissues and kidneys. Indications: hyperuricemy (the serum level of uric acid is 500 mkmol (8.5 mg/100 ml) or higher and non-diet controlled); diseases caused by increased serum uric acid levels, especially in patients with gout, urate nephropathy and urate urolithiasis. Contact us for more information.
Read more


Sales markets Western Europe; Eastern Europe
Supplied from Ukraine
Selling Points International Approvals/Standards; Quality Service
Show more specifications

More products from BCPP (Borshchahivskiy CPP)

View all our products (109)

Products from other suppliers

Allopurinol / m04a a01

Contact information




View all contact information